Becton, Dickinson & Co. expands the Class I recall of millions of its Q-Syte Luer access intravenous systems to include its Nexiva IV catheter.
Becton, Dickinson & Co. (NYSE:BDX) voluntarily expanded the Class I recall of millions of its Q-Syte Luer access devices to include its Nexiva intravenous catheter systems.
The recall, initiated last October, was prompted by complaints that air was introduced in to device through its septum's bottom disk, potentially leading to air embolisms or leakage that could cause serious injury or death. The Nexiva devices contain two of the Q-Syte components containing the defect, which was caused by a "manufacturing deviation," BD said.
The defect occurred in about 2.8 million BD Q-Syte and 2.9 million BD Nexiva units containing 5 million BD Q-Syte devices distributed from November 2008 to November 2009 in the U.S., Asia, Canada, Europe, Mexico, the Middle East, South Africa and South America. BD said it corrected the problem and expects the recall to have a negligible effect on its books.
The recall affects the following catalog and lot numbers:
Warren Watson, a 30-year Medtronic Inc. employee with family connections to founder Earl Bakken, is...
Quidel Corp. wins Food & Drug Administration 510(k) clearance for its chorionic gonadotropin-...
Ann Arbor, Mich.-based HistoSonics Inc. snags former Food & Drug Administration commissioner Dr....
The Food & Drug Administration releases a list of the medical devices it granted 510(k) clearance...
A federal grand jury indicts former Spectranetics CEO John Schulte, two other executives and a...